PINK
INVVY

INDIVIOR PLC ADR

Pharmaceuticals
Healthcare

Prices are adjusted according to historical splits.

INDIVIOR PLC ADR Stock Price

Vitals

Today's Low:
$21.64
Today's High:
$21.8455
Open Price:
$21.65
52W Low:
$14.76
52W High:
$35.5
Prev. Close:
$22.25
Volume:
8103

Company Statistics

Market Cap.:
$3.01 billion
Book Value:
0.522
Revenue TTM:
$947 million
Operating Margin TTM:
24.18%
Gross Profit TTM:
$742 million
Profit Margin:
-5.28%
Return on Assets TTM:
8.23%
Return on Equity TTM:
-32.9%

Company Profile

INDIVIOR PLC ADR had its IPO on under the ticker symbol INVVY.

The company operates in the Healthcare sector and Pharmaceuticals industry. INDIVIOR PLC ADR has a staff strength of 1,000 employees.

Stock update

Shares of INDIVIOR PLC ADR opened at $21.65 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $21.64 - $21.85, and closed at $21.85.

This is a -1.82% slip from the previous day's closing price.

A total volume of 8,103 shares were traded at the close of the day’s session.

In the last one week, shares of INDIVIOR PLC ADR have increased by +4.52%.

INDIVIOR PLC ADR's Key Ratios

INDIVIOR PLC ADR has a market cap of $3.01 billion, indicating a price to book ratio of 13.747 and a price to sales ratio of 3.473.

In the last 12-months INDIVIOR PLC ADR’s revenue was $947 million with a gross profit of $742 million and an EBITDA of $241 million. The EBITDA ratio measures INDIVIOR PLC ADR's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, INDIVIOR PLC ADR’s operating margin was 24.18% while its return on assets stood at 8.23% with a return of equity of -32.9%.

In Q1, INDIVIOR PLC ADR’s quarterly earnings growth was a positive 10.7% while revenue growth was a positive 22.2%.

INDIVIOR PLC ADR’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-0.35 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into INDIVIOR PLC ADR’s profitability.

INDIVIOR PLC ADR stock is trading at a EV to sales ratio of 2.7117 and a EV to EBITDA ratio of 9.6831. Its price to sales ratio in the trailing 12-months stood at 3.473.

INDIVIOR PLC ADR stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$1.73 billion
Total Liabilities
$972.00 million
Operating Cash Flow
$0
Capital Expenditure
$1 million
Dividend Payout Ratio
0%

INDIVIOR PLC ADR ended 2024 with $1.73 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.73 billion while shareholder equity stood at $117.00 million.

INDIVIOR PLC ADR ended 2024 with $0 in deferred long-term liabilities, $972.00 million in other current liabilities, in common stock, $1.36 billion in retained earnings and $0 in goodwill. Its cash balance stood at $592.00 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $236.00 million.

INDIVIOR PLC ADR’s total current assets stands at $1.09 billion while long-term investments were $0 and short-term investments were $97.00 million. Its net receivables were $229.00 million compared to accounts payable of $53.00 million and inventory worth $131.00 million.

In 2024, INDIVIOR PLC ADR's operating cash flow was $0 while its capital expenditure stood at $1 million.

Comparatively, INDIVIOR PLC ADR paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$21.85
52-Week High
$35.5
52-Week Low
$14.76
Analyst Target Price
$

INDIVIOR PLC ADR stock is currently trading at $21.85 per share. It touched a 52-week high of $35.5 and a 52-week low of $35.5. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $24.24 and 200-day moving average was $21.39 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 7.8% are held by institutions.

Frequently Asked Questions About INDIVIOR PLC ADR

The stock symbol (also called stock or share ticker) of INDIVIOR PLC ADR is INVVY

The IPO of INDIVIOR PLC ADR took place on

Similar Industry Stocks (Pharmaceuticals)

Last Price
Chg
Chg%
$10.53
-0.01
-0.09%
Abbott India Limited (ABBOTINDIA)
$22897.25
-87.85
-0.38%
INFOSYS LTD. (INFY)
$1500.8
24.45
+1.66%
$0.52
-0.03
-5.97%
$1.4
0.02
+1.45%
$236.88
-2.11
-0.88%
$218.65
-11.3
-4.91%
$54.94
-0.47
-0.85%
$24.05
-0.49
-2%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company’s product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Address

10710 Midlothian Turnpike, North Chesterfield, VA, United States, 23235